J&J and Cook: Win a Little, Lose a Little
Executive Summary
Some Johnson & Johnson supporters are gloating publicly over the company's recent settlement of its litigation against Cook Group Inc. for violating patents on its Palmaz-Schatz coronary stent. J&J announced in early February that it agreed to license rights to the patent to Cook in exchange for royalty payments; terms were not disclosed. J&J's release called the settlement "amicable." But the outcome is actually far from black and white.